View Older Stories View More Recent Stories

Aug 7, 2019 05:10PM New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRA® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome
Aug 7, 2019 05:10PM New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRA® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome
Aug 7, 2019 07:00AM Ionis Reports Second Quarter 2019 Financial Results
Aug 6, 2019 05:14PM Akcea Therapeutics (AKCA), Ionis (IONS) Announce BROADEN Study with WAYLIVRA in Patients with FPL Met its Primary Endpoint
Aug 6, 2019 04:05PM Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRA® (volanesorsen) in Patients with Familial Partial Lipodystrophy
Aug 6, 2019 04:05PM Akcea Reports Financial Results and Highlights for Second Quarter 2019
Aug 6, 2019 04:05PM Akcea and Ionis Report Top-line Results from the BROADEN Study with WAYLIVRA® (volanesorsen) in Patients with Familial Partial Lipodystrophy
Aug 6, 2019 04:05PM Akcea Reports Financial Results and Highlights for Second Quarter 2019
Jul 29, 2019 07:00AM Akcea Therapeutics to Hold Second Quarter 2019 Financial Results Webcast
Jul 29, 2019 07:00AM Akcea Therapeutics to Hold Second Quarter 2019 Financial Results Webcast
Jul 16, 2019 07:00AM hATTR Compass™ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch
Jul 16, 2019 07:00AM hATTR Compass™ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch
Jun 26, 2019 07:00AM Akcea and Ionis Announce Upcoming Data Presentations at the 5th European Academy of Neurology Annual Congress
Jun 26, 2019 07:00AM Akcea and Ionis Announce Upcoming Data Presentations at the 5th European Academy of Neurology Annual Congress
Jun 20, 2019 04:38PM Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting
Jun 20, 2019 04:38PM Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting
May 28, 2019 07:00AM Akcea Therapeutics to Present at Upcoming Investor Conferences
May 28, 2019 07:00AM Akcea Therapeutics to Present at Upcoming Investor Conferences
May 9, 2019 07:00AM Ionis reports first quarter 2019 financial results
May 8, 2019 04:05PM Akcea Reports Financial Results and Highlights for First Quarter 2019
May 8, 2019 04:05PM Akcea Reports Financial Results and Highlights for First Quarter 2019
May 7, 2019 04:05PM New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)
May 7, 2019 04:05PM New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)
May 7, 2019 08:43AM Akcea Therapeutics (AKCA), Ionis (IONS) Announce Approval of WAYLIVRA in European Union
May 7, 2019 08:41AM Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union
May 7, 2019 08:41AM Akcea and Ionis Announce Approval of WAYLIVRA® (volanesorsen) in the European Union
May 2, 2019 07:05AM Akcea Announces Upcoming Data Presentations at the 2019 American Academy of Neurology Meeting (AAN.19)
May 2, 2019 07:05AM Akcea Announces Upcoming Data Presentations at the 2019 American Academy of Neurology Meeting (AAN.19)
May 1, 2019 07:05AM Positive clinical data at AAN 2019 reinforces Ionis' commitment to delivering life-changing medicines to patients with neurological diseases
Apr 24, 2019 07:00AM Akcea Therapeutics to Hold First Quarter 2019 Financial Results Webcast
Apr 24, 2019 07:00AM Akcea Therapeutics to Hold First Quarter 2019 Financial Results Webcast
Mar 15, 2019 04:06PM Akcea Therapeutics (AKCA), Ionis (IONS) Announce Upcoming Data Presentations at ACC.19
Mar 15, 2019 04:05PM Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19)
Mar 15, 2019 04:05PM Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19)
Mar 7, 2019 07:05AM Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Mar 1, 2019 07:48AM Ionis Pharmaceuticals Inc. (IONS), Akcea Therapeutics (AKCA) Report Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)
Mar 1, 2019 07:45AM Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)
Mar 1, 2019 07:45AM Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)
Feb 28, 2019 07:00AM Akcea® Recognizes Rare Disease Day Through Efforts to Increase Awareness of Hereditary Transthyretin Amyloidosis and Familial Chylomicronemia Syndrome
Feb 28, 2019 07:00AM Akcea® Recognizes Rare Disease Day Through Efforts to Increase Awareness of Hereditary Transthyretin Amyloidosis and Familial Chylomicronemia Syndrome
Feb 27, 2019 07:00AM Ionis Exceeds 2018 Financial Guidance
Feb 26, 2019 04:05PM Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018
Feb 26, 2019 04:05PM Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018
Feb 25, 2019 01:15AM AKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to License
Feb 25, 2019 01:15AM AKCEA-APO(a)-LRx Advances as Leading Pharmaceutical Company Exercises Option to License
Feb 20, 2019 07:00AM Akcea Therapeutics to Present at Upcoming Investor Conferences
Feb 20, 2019 07:00AM Akcea Therapeutics to Present at Upcoming Investor Conferences
Feb 13, 2019 04:05PM Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast
Feb 13, 2019 04:05PM Akcea Therapeutics to Hold Fourth Quarter and Full Year 2018 Financial Results Webcast
Feb 13, 2019 07:05AM Ionis Pharmaceuticals to Hold 2018 Financial Results Webcast
View More Recent Stories View Older Stories